Pro Tip: Learn how to use HBI Alerts to follow your favorite topics

United Kingdom

 

New weight loss drugs to create $100bn+ private health care market

New highly effective weight loss drugs could create a market worth more than $100bn in annual revenue by 2030. Whilst the majority of this value will be captured by the pharma industry, HBI hears there will be a significant role for specialised clinical providers who can deliver these medicines alongside behavioural and lifestyle changes. 

Operose set to sell

Primary care group Operose is being sold to HCRG Care Group, a UK healthcare provider. It is the last of the three major Europe-based groups to be sold off by US insurance company Centene.

UK tightens foreign recruitment visas

This week, the UK’s Home Secretary James Cleverly announced government plans to tighten health and care worker visas. HBI speaks to a global workforce expert to understand what this attempt to prioritise ‘British talent first’ will mean for operators already facing a workforce crisis.

NHS struggling to fund outsourcing needs

HBI hears financial pressure on the UK NHS is making it increasingly difficult to outsource to the private sector – but with waiting lists worse than expected, there are still opportunities for for-profit operators. Who is most likely to take advantage?

PureHealth set to IPO

UAE-based healthcare provider PureHealth looks set to IPO in the coming months, with multiple sources suggesting it will list on the Abu Dhabi Securities Exchange.

Interview: Jim Easton, CEO Practice Plus Group

Jim Easton is the CEO of Practice Plus Group, one of the UK’s major hospital operators. In June, HBI reported the group planned to offer a middle-market self-pay option – delivering elective surgeries like knee and hip replacements at around 75% of the usual price. Has the market's changing attitude to PMI shifted its focus?

Find Us